Mito, Estado y Derecho

by Alberto J. Montero
Published 2018-06-01

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

by Vinay Gudena, Alberto J Montero, Stefan Glück
Published 2008-10-01

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

by Pui S. Tan, Benjamin Haaland, Alberto J. Montero, Christos E. Kyriakopoulos, Gilberto Lopes
Published 2014-03-01

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

by Pui S. Tan, Benjamin Haaland, Alberto J. Montero, Christos E. Kyriakopoulos, Gilberto Lopes
Published 2014-01-01

Treating Breast Cancer in the 21st Century: Emerging Biological Therapies

by Gabriel Tinoco, Sean Warsch, Stefan Glück, Kiran Avancha, Alberto J. Montero
Published 2013-01-01

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

by Simon B. Zeichner, Tadeu Ambros, John Zaravinos, Alberto J. Montero, Reshma L. Mahtani, Eugene R. Ahn, Aruna Mani, Nathan J. Markward, Charles L. Vogel
Published 2015-01-01

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

by Simon B. Zeichner, Tadeu Ambros, John Zaravinos, Alberto J. Montero, Reshma L. Mahtani, Eugene R. Ahn, Aruna Mani, Nathan J. Markward, Charles L. Vogel
Published 2015-04-01

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

by Linda T. Vahdat, Peter Schmid, Andres Forero-Torres, Kimberly Blackwell, Melinda L. Telli, Michelle Melisko, Volker Möbus, Javier Cortes, Alberto J. Montero, Cynthia Ma, Rita Nanda, Gail S. Wright, Yi He, Thomas Hawthorne, Rebecca G. Bagley, Abdel-Baset Halim, Christopher D. Turner, Denise A. Yardley
Published 2021-05-01